Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device David Dobarro, MD, Marian Urban, MD, Karen.

Slides:

Advertisements

Similar presentations

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.

Advertisements

Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,

Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,

Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.

Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy? Wayne C. Levy,

Jennifer A. Cowger, MD, Matthew A

The Journal of Heart and Lung Transplantation

Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study Waldemar.

Boot Camp for Ventricular Assist Device Patient Recovery beyond Medical Management E.A. Hamad, V. Devlin, K. McDonnell, N. Robinson, M. Welsh, E. Kerr,

Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

Severe Mitral Regurgitation at Time of Left Ventricular Assist Device Implantation - Comparison of Systematic Mitral Valve Repair vs Surgical Abstention

Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm.

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A

The Value of Percutaneous Coronary Intervention in Aortic Valve Stenosis with Coronary Artery Disease Ronny Alcalai, MD, Nicola Viola, MD, Morris Mosseri,

Martin Strueber, MD, Anna L

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Long-term prognosis of ascending aortic aneurysm after aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis Evaldas Girdauskas,

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

Dhaval Chauhan, MD, Alexis K

An Extended Role of Continuous Flow Device in Pediatric Mechanical Circulatory Support Ed Peng, FRCS(CTh), Richard Kirk, FRCP, Neil Wrightson, BS, Phuoc.

Less Is More in Post Pediatric Heart Transplant Care

Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery? Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,

Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair Athanasios Saratzis, MBBS, MRCS,

Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort Leah Backhus, MD, Jonathon Sargent, BS, Aaron.

Paul Szabolcs, Donna Niedzwiecki

Intra-aortic balloon pump therapy negatively affects flow through a continuous-flow left ventricular assist device Dipanjan Banerjee, MD, MS, Chun Choi,

Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation Ann C.

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Outcomes after implantation of partial-support left ventricular assist devices in inotropic- dependent patients: Do we still need full-support assist devices?

Volume 7, Issue 11, (November 2010)

Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function Toshinobu.

Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome Kevin G. Soucy, PhD, Steven.

Long-term outcome of patients on continuous-flow left ventricular assist device support Koji Takeda, MD, PhD, Hiroo Takayama, MD, PhD, Bindu Kalesan,

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Ranjit John, MD, Yoshifumi Naka, MD, Soon J

Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Dhaval Chauhan, MD, Alexis K

Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease Joy P. Walker, MD, Jade.

It’s All in the “Swerve of the Curve”

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Outcome of Patients With Aortic Stenosis Referred to a Multidisciplinary Meeting for Transcatheter Valve Marjan Jahangiri, FRCS, Jean Claude Laborde,

Durable Ventricular Assist Device Support for Failing Systemic Morphologic Right Ventricle: Early Results Ed Peng, FRCS(CTh), John J. O’Sullivan, FRCP(UK),

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? Mathew Williams, MD, Jennifer Casher,

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure Nathan Wm. Skelley, BS, Jeremiah.

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit.

Vinod H. Thourani, MD, W. Brent Keeling, MD, Robert A

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

Current Status of Left Ventricular Assist Device Therapy

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew.

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs,

Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical risk Lenard.

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Successful HeartWare Bridge to Recovery in a 3-Year Old: A Game Changer? Richard Kirk, FRCP, Ed Peng, FRCS (CTh), Andrew Woods, BS, Julie Flett, RGN,

Outcomes after endovascular abdominal aortic aneurysm repair are equivalent between genders despite anatomic differences in women Luc Dubois, MD, MSc,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Presentation transcript:

Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device David Dobarro, MD, Marian Urban, MD, Karen Booth, MB, Neil Wrightson, BS, Javier Castrodeza, MD, Jerome Jungschleger, MD, Nicola Robinson-Smith, BA, Andrew Woods, BA, Gareth Parry, FRCP, Stephan Schueler, MD, Guy A. MacGowan, MD, FACC The Journal of Heart and Lung Transplantation Volume 36, Issue 1, Pages 42-49 (January 2017) DOI: 10.1016/j.healun.2016.08.006 Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 1 Kaplan-Meier survival curves for aortic valve opening (AVO) in the (A) entire cohort and (B) in the 30-days-out cohort. LVAD, left ventricular assist device. The Journal of Heart and Lung Transplantation 2017 36, 42-49DOI: (10.1016/j.healun.2016.08.006) Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 2 Kaplan-Meier survival curves. (A) Aortic valve opening (AVO) and combined event-free survival. (B) AVO and pump thromobisis (PT)-free survival. LVAD, left ventricular assist device. The Journal of Heart and Lung Transplantation 2017 36, 42-49DOI: (10.1016/j.healun.2016.08.006) Copyright © 2016 International Society for Heart and Lung Transplantation Terms and Conditions